Concepedia

Long-term survival outcomes of salvage [225Ac]Ac-PSMA-617 targeted alpha therapy in patients with PSMA-expressing end-stage metastatic castration-resistant prostate cancer: a real-world study

Sanjana Ballal, Madhav Prasad Yadav, Swayamjeet Satapathy, Shobhana Raju, Madhavi Tripathi, Ranjit Kumar Sahoo, Chandrasekhar Bal

European Journal of Nuclear Medicine and Molecular Imaging · 2023 · 36 citations · 13 references

DOI

Concepts

References

13

Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer

Oliver Sartor, Johann S. de Bono, Kim N. et al. · New England Journal of Medicine · 2021 · 2.6K citations · Full text

, , +17

Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3

Howard I. Scher, Michael J. Morris, Walter M. Stadler et al. · Journal of Clinical Oncology · 2016 · 1.6K citations

, , +17

[177Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study

Michael S. Hofman, John Violet, Rodney J. Hicks et al. · The Lancet Oncology · 2018 · 1.1K citations

, , +14

<sup>225</sup>Ac-PSMA-617 for PSMA-Targeted α-Radiation Therapy of Metastatic Castration-Resistant Prostate Cancer

Clemens Kratochwil, Frank Bruchertseifer, Frederik L. Giesel et al. · Journal of Nuclear Medicine · 2016 · 1.1K citations · Full text

, , +17

Targeted α-Therapy of Metastatic Castration-Resistant Prostate Cancer with <sup>225</sup>Ac-PSMA-617: Dosimetry Estimate and Empiric Dose Finding

Clemens Kratochwil, Frank Bruchertseifer, Hendrik Rathke et al. · Journal of Nuclear Medicine · 2017 · 496 citations · Full text

, , +17